GLP1 Agonists - Miracle, Mirage or Minefield and Post-Partum Depression
Jul 14
Two situations are playing out in clinics right now, often quietly, and both carry real consequences if they're missed.
The first: a client on a GLP-1 agonist, delighted with the number on the scale, with no idea that up to 40 to 60 percent of that weight loss can be lean muscle rather than fat. Muscle she needs for her metabolic rate, her glucose control, her strength and bone mass as she ages. Left unsupported, many people come off these medications within a year, often regaining the weight, often with less muscle than they started with. The global market for these medications is projected to reach around 82.5 billion US dollars by 2032. This is not a passing trend. These clients are already in your clinic; they are thinking about taking the medication, are taking it already, or are stopping it. In each of these cases you can give them a great deal of support and guidance.
The second: a new mother whose low mood, anxiety or dark thoughts are being dismissed as normal exhaustion. Suicide is one of the leading causes of death in pregnancy and the postpartum period in developed countries. Postpartum psychosis affects roughly one in a thousand births, which sounds rare until you realise how many births that represents each year. Left unrecognised, these are not just missed opportunities to help. They're missed opportunities to catch something serious in time.
Both situations share something important. The people affected are already speaking to natural healthcare clinicians. The question is whether we're equipped to recognise what's happening and respond well.
That's why we've put together two presentations worth your time.
GLP-1 Agonists: Miracle, Mirage or Minefield, a two-part series with Dr Faryal Luhar, covers what these medications actually do in the body, the practical assessment framework for consultations, and how to support clients through any GI side effects, nutrient absorption, muscle preservation and sustainable habits, particularly once the medication stops. Included in this course are the two eating disorder questionnaires that Dr Luhar uses.
Post-Partum Depression, with Dr Kim Callaghan, covers risk factors, the screening questions that matter, and where thyroid function, iron status and other naturopathic considerations fit into a genuinely useful care plan. She closes with real case studies that show how these pieces come together in practice.
Both speakers are naturopathic doctors working with these exact issues in their own clinics, and both sessions are built to be immediately usable in your practice.
The first: a client on a GLP-1 agonist, delighted with the number on the scale, with no idea that up to 40 to 60 percent of that weight loss can be lean muscle rather than fat. Muscle she needs for her metabolic rate, her glucose control, her strength and bone mass as she ages. Left unsupported, many people come off these medications within a year, often regaining the weight, often with less muscle than they started with. The global market for these medications is projected to reach around 82.5 billion US dollars by 2032. This is not a passing trend. These clients are already in your clinic; they are thinking about taking the medication, are taking it already, or are stopping it. In each of these cases you can give them a great deal of support and guidance.
The second: a new mother whose low mood, anxiety or dark thoughts are being dismissed as normal exhaustion. Suicide is one of the leading causes of death in pregnancy and the postpartum period in developed countries. Postpartum psychosis affects roughly one in a thousand births, which sounds rare until you realise how many births that represents each year. Left unrecognised, these are not just missed opportunities to help. They're missed opportunities to catch something serious in time.
Both situations share something important. The people affected are already speaking to natural healthcare clinicians. The question is whether we're equipped to recognise what's happening and respond well.
That's why we've put together two presentations worth your time.
GLP-1 Agonists: Miracle, Mirage or Minefield, a two-part series with Dr Faryal Luhar, covers what these medications actually do in the body, the practical assessment framework for consultations, and how to support clients through any GI side effects, nutrient absorption, muscle preservation and sustainable habits, particularly once the medication stops. Included in this course are the two eating disorder questionnaires that Dr Luhar uses.
Post-Partum Depression, with Dr Kim Callaghan, covers risk factors, the screening questions that matter, and where thyroid function, iron status and other naturopathic considerations fit into a genuinely useful care plan. She closes with real case studies that show how these pieces come together in practice.
Both speakers are naturopathic doctors working with these exact issues in their own clinics, and both sessions are built to be immediately usable in your practice.
All Courses | CE Hours | Help | Students | Presenters | Legals | Reimbursement | Become a Member | About | Contact
Sign-Up to Our Newsletter | Course Updates and News | Freebies and More
More coming your way soon! No spam. Promise.